Catalyst Wire Dossier Catalyst Wire Dossier

Novel endocrine therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Novel endocrine therapy, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study [NA]

See pricing